ENGN US Equity

enGene Therapeutics Inc.

Nasdaq+ Compare Tear sheet →

Health Care · Biological Products, (No Diagnostic Substances) · CIK 1980845 · FY ends Oct 31

$1.78

+0.01 (+0.56%)

USD · as of 2026-08-21 · marketstack

Switch Ticker

8-K & ownership events Filings index (FLNG)

Documents (DOC)Legal & controls (LGCT)

Documents

3 of 3 10-Ks readable here

Period end	Filed	Form	Read here	EDGAR
2025-10-31	2025-12-22	10-K	read · risk factors · MD&A	index · original · 0001193125-25-328743
2024-10-31	2024-12-19	10-K	read · risk factors · MD&A	index · original · 0000950170-24-138472
2023-10-31	2024-01-29	10-K	read · risk factors · MD&A	index · original · 0000950170-24-008125

▾Risk registerwhich risk-factor headings appeared in which year

62 captions · 3 filings

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

62 captions across 3 filings12 added10 dropped40 in every year3 of 3 10-Ks on file are cached here

2023	2024	2025	Years
·	·	●	1
·	·	●	1
·	●	●	2
·	●	●	2
·	●	●	2
·	●	●	2
·	●	●	2
·	●	●	2
·	●	●	2
·	●	●	2
·	●	●	2
·	●	●	2
·	●	·	1
●	●	·	2 rw
●	·	·	1
●	·	·	1
●	·	·	1
●	·	·	1
●	·	·	1
●	·	·	1
●	·	·	1
●	·	·	1
●	●	●	3 rw
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3 rw
●	●	●	3
●	●	●	3
●	●	●	3 rw
●	●	●	3 rw
●	●	●	3
●	●	●	3 rw
●	●	●	3
●	●	●	3 rw
●	●	●	3 rw
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3 rw
●	●	●	3
●	●	●	3 rw
●	●	●	3 rw
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3 rw
●	●	●	3 rw
●	●	●	3 rw
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3
●	●	●	3 rw
●	●	●	3

Risk-factor caption

2023

2024

2025

Years

●

2 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

3 rw

●

The filer's own 10-K text · 3 filings read

Rows are the filing's own headings, verbatim — nothing is summarized or generated.

A blank cell means the filer did not print that heading that year — not that the risk ended.

Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.

▾Filing languagedocument length, negation and hedging — chart it against price on GRAPH

3 filings measured

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

Filed	Period end	Document words	Item 1A words	Negation / 10k	Hedging / 10k	Filing
2024-01-29	2023-10-31	130,631	49,143	62.47	172.32	read · EDGAR ↗
2024-12-19	2024-10-31	111,299	52,275	68.64	193.89	read · EDGAR ↗
2025-12-22	2025-10-31	97,619	51,964	71.4	206.21	read · EDGAR ↗

plot against the price on GRAPH: Document length · Item 1A length · Negation per 10k words · Hedging per 10k words

The filer's own 10-K text · 3 filings measured

House wordlists, not a licensed dictionary and not tuned against returns.

9 negation words · 40 hedging words — hover to read both lists.

Each point sits at its filing date and is held flat until the next filing.

ENGN US Equity☆

Documents

▾Risk registerwhich risk-factor headings appeared in which year

▾Filing languagedocument length, negation and hedging — chart it against price on GRAPH

ENGN US Equity